• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强心剂的研究。IV. 带有取代乙内酰脲和2-硫代乙内酰脲环的新型1-(6,7-二甲氧基-4-喹唑啉基)哌啶衍生物的合成。

Studies on cardiotonic agents. IV. Synthesis of novel 1-(6,7-dimethoxy-4-quinazolinyl)piperidine derivatives carrying substituted hydantoin and 2-thiohydantoin rings.

作者信息

Nomoto Y, Takai H, Hirata T, Teranishi M, Ohno T, Kubo K

机构信息

Tokyo Research Laboratory, Kyowa Hakko Kogyo Co., Ltd., Japan.

出版信息

Chem Pharm Bull (Tokyo). 1990 Nov;38(11):3014-9. doi: 10.1248/cpb.38.3014.

DOI:10.1248/cpb.38.3014
PMID:2085880
Abstract

A series of novel 1-(6,7-dimethoxy-4-quinazolinyl)piperidines carrying substituted hydantoin and 2-thiohydantoin rings was synthesized and examined for cardiotonic activity in anesthetized dogs. Introduction of isopropyl and sec-butyl group at the 5-position of the hydantoin and thiohydantoin rings led to potent inotropic activity. Effects of insertion of an alkyl chain between the piperidine and the hydantoin rings were also examined. The structural requirements necessary for optimal cardiotonic activity within the series were investigated.

摘要

合成了一系列带有取代乙内酰脲和2-硫代乙内酰脲环的新型1-(6,7-二甲氧基-4-喹唑啉基)哌啶,并在麻醉犬中检测其强心活性。在乙内酰脲和硫代乙内酰脲环的5-位引入异丙基和仲丁基导致了强效的正性肌力活性。还研究了在哌啶和乙内酰脲环之间插入烷基链的影响。研究了该系列中实现最佳强心活性所需的结构要求。

相似文献

1
Studies on cardiotonic agents. IV. Synthesis of novel 1-(6,7-dimethoxy-4-quinazolinyl)piperidine derivatives carrying substituted hydantoin and 2-thiohydantoin rings.强心剂的研究。IV. 带有取代乙内酰脲和2-硫代乙内酰脲环的新型1-(6,7-二甲氧基-4-喹唑啉基)哌啶衍生物的合成。
Chem Pharm Bull (Tokyo). 1990 Nov;38(11):3014-9. doi: 10.1248/cpb.38.3014.
2
Studies on cardiotonic agents. III. Synthesis of 1-[1-(6,7-dimethoxy-4-quinazolinyl)-4-piperidinyl]-3-substituted 2-imidazolidinone and 2-imidazolidinethione derivatives.
Chem Pharm Bull (Tokyo). 1990 Sep;38(9):2467-71. doi: 10.1248/cpb.38.2467.
3
Studies on cardiotonic agents. V. Synthesis of 1-(6,7-dimethoxy-4-quinazolinyl)piperidine derivatives carrying various 5-membered heterocyclic rings at the 4-position.
Chem Pharm Bull (Tokyo). 1991 Jan;39(1):86-90. doi: 10.1248/cpb.39.86.
4
Studies on cardiotonic agents. VI. Synthesis of novel 4,5-dihydro-3(2H)-pyridazinone derivatives carrying some benzoheterocycles at the 6-position.
Chem Pharm Bull (Tokyo). 1991 Feb;39(2):352-7. doi: 10.1248/cpb.39.352.
5
Studies on cardiotonic agents. VII. Potent cardiotonic agent KF15232 with myofibrillar Ca2+ sensitizing effect.
Chem Pharm Bull (Tokyo). 1991 Apr;39(4):900-10. doi: 10.1248/cpb.39.900.
6
Studies on cardiotonic agents. I. Synthesis of some quinazoline derivatives.
Chem Pharm Bull (Tokyo). 1990 Jun;38(6):1591-5. doi: 10.1248/cpb.38.1591.
7
Structural requirements for hydantoins and 2-thiohydantoins to induce lymphoproliferative popliteal lymph node reactions in the mouse.乙内酰脲和2-硫代乙内酰脲诱导小鼠腘淋巴结淋巴细胞增生反应的结构要求。
Int J Immunopharmacol. 1988;10(8):997-1010. doi: 10.1016/0192-0561(88)90047-1.
8
Synthesis and search for anticonvulsive and hypoglycemic properties of novel 5-benzylidene derivatives of 3-o-chloro- and 3-o-methylbenzoyl-2-thiohydantoin.
Pol J Pharmacol Pharm. 1987 May-Jun;39(3):237-44.
9
5,5-Diaryl-2-thiohydantoins and 5,5-diaryl-N3-substituted-2-thiohydantoins as potential hypolipidemic agents.5,5-二芳基-2-硫代乙内酰脲和5,5-二芳基-N3-取代-2-硫代乙内酰脲作为潜在的降血脂药物。
J Med Chem. 1986 May;29(5):855-9. doi: 10.1021/jm00155a042.
10
Synthesis of hydantoins and thiohydantoins spiro-fused to pyrrolidines: druglike molecules based on the 2-arylethyl amine scaffold.与吡咯烷螺稠合的乙内酰脲和硫代乙内酰脲的合成:基于2-芳基乙胺支架的类药物分子。
J Comb Chem. 2009 Jul-Aug;11(4):527-38. doi: 10.1021/cc800190z.

引用本文的文献

1
The Bucherer-Bergs Multicomponent Synthesis of Hydantoins-Excellence in Simplicity.布赫雷尔-伯格斯多元醇合成海因-简单的卓越。
Molecules. 2021 Jun 30;26(13):4024. doi: 10.3390/molecules26134024.